跳至主要内容
临床试验/NCT05806801
NCT05806801招募中不适用

Metabolic Adaptations to Weight Loss With and Without Exercise

University of Michigan1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2023年7月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
68
试验地点
1
主要终点
Adipose tissue fibrosis

研究概览

简要总结

Study Purpose:

The combination of caloric restriction and exercise is the most common first-line treatment for obesity-related disorders, yet we know very little about how these two very different treatments work together. A deeper understanding about mechanisms underlying the health benefits of adding exercise to a weight loss program will not only aid efforts to optimize more effective lifestyle interventions, but it can also uncover novel targets for the treatment/prevention of obesity-related diseases.

Although a reduction in body fat is the fundamental adaptation to weight loss, we know almost nothing about the effects that adding exercise has on structural and functional changes within fat tissue that may further enhance metabolic health. This is very important because many obesity-related metabolic health complications are tightly linked with abnormalities in abdominal fat tissue. We argue exercise-induced modifications in abdominal fat tissue will reveal persistent health benefits even if some weight is regained

Study Summary:

10% Weight Loss Phase - Subject participation in the study will involve a series of metabolic tests before, at midpoint, and after undergoing a 10% weight loss program (with or without exercise training depending on group randomization). During this, subjects will be randomized into one of two different experimental groups:

  1. Moderate Intensity Continuous Training (MICT) exercise group
  2. No exercise (control) group

Follow-up Phase: After completing the metabolic testing post-weight loss, all study-related diet and exercise supervision will end and subjects will be free to make their own choices regarding diet and exercise/physical activity behavior. Subjects will then be asked to complete follow-up testing at 2-, 4- and 6- months post-weight loss.

Total involvement in the study for each subject will likely be about 10-13 months (4-7 months during weight loss phase, 6 months during follow-up phase).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 18-40
  • Body Mass Index: 30-40 kg/m2
  • Weight stable (±3kg for greater than or equal to about 2 months)
  • No regularly planned exercise/physical activity
  • Women must have regularly occurring menses and must be premenopausal

排除标准

  • EKG abnormalities
  • Evidence/history of cardiovascular disease, diabetes or other metabolic disease
  • Medications known to affect lipid or glucose metabolism
  • Pregnant or lactating
  • Tobacco or e-cigarette use
  • Prior experience of hypersensitivity to insulin, human albumin, and potassium chloride injection.
  • Allergies/hypersensitivity to local anesthetics of the amide type (e.g., lidocaine)
  • History of hyperkalemia or potential for developing hyperkalemia (including but not limited to taking drugs that may induce hyperkalemia such as cardiac glycosides or potassium sparing diuretics)
  • Anti-coagulant medication (e.g., Coumadin, Rivaroxaban) and Lidocaine allergy/sensitivity are exclusion criteria for the biopsy procedure.

研究组 & 干预措施

Moderate Intensity Continuous Training (MICT) exercise group

Experimental

45 minutes of continuous steady-state exercise at 70% maximal heart rate throughout the 10% weight loss phase of the study

干预措施: MICT Exercise (Behavioral)

No exercise (Control)

Experimental

to remain sedentary (no planned physical exercise) throughout the duration of the 10% weight loss phase of the study

干预措施: No Exercise (Control) (Behavioral)

结局指标

主要结局

Adipose tissue fibrosis

时间窗: 30 minutes

measured histologically using Sirus Red Staining, quantified using ImageJ software

Insulin sensitivity

时间窗: 2 hours

a hyperinsulinemic-euglycemic clamp will be used to quantify peripheral insulin sensitivity

Fatty acid turnover

时间窗: 2 hours

stable isotope tracer infusion methods will be used to assess fatty acid turnover

Adipose tissue capillarization

时间窗: 30 minutes

measured immunohistochemically using an antibody for CD31, quantified using ImageJ software

次要结局

  • Body weight change(6 months)
  • Body fat mass(30 minutes)
  • Oral Glucose Tolerance Test (OGTT)(2 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeffrey F Horowitz

Professor of Movement Science and Director of the Substrate Metabolism Laboratory (SML) at the University of Michigan School of Kinesiology

University of Michigan

研究点 (1)

Loading locations...

相似试验